LIVZON PHARMA (01513) spent 8.7832 million yuan on September 24 to repurchase 250,000 shares of A shares.

18:35 24/09/2024

Lizhu Pharmaceutical (01513) announced that the company invested 8.7832 million yuan on September 24, 2024...

LIVZON PHARMA (01513) announced that the company spent 8.7832 million yuan to repurchase 250,000 A shares on September 24, 2024. The repurchase price was between 34.95 yuan and 35.76 yuan per share.

HAO WEN HLDGS (08019) Enters into a Supplementary Memorandum of Understanding with Chengmai Junli

ZJ UNITED INV (08366): Fu Enming appointed as authorized representative

YU TAK INT'L (08048) announced its mid-year performance for 2025, with a net loss attributable to shareholders of HK$1.049 million, a year-on-year decrease of 83.26%.

HAO WEN HLDGS (08019) Enters into a Supplementary Memorandum of Understanding with Chengmai Junli

ZJ UNITED INV (08366): Fu Enming appointed as authorized representative

YU TAK INT'L (08048) announced its mid-year performance for 2025, with a net loss attributable to shareholders of HK$1.049 million, a year-on-year decrease of 83.26%.